The Synova WAVE replaces slow, costly enzymatic methods with shockwave-powered adipose stem cell separation — delivering higher viability, higher yield, and a dramatically better experience for your patients and your bottom line.
Traditional collagenase methods require 1–4 hours, tying up lab resources, delaying procedures, and forcing patients into a second visit. That's a second scheduling slot, a second no-show risk, and revenue left on the table.
Enzymatic processing is classified as "more than minimal manipulation" — placing your clinic in a regulatory gray area. The FDA issued enforcement actions against 40+ clinics in 2024–2025. Don't be next.
Harsh enzymatic breakdown damages delicate stem cells. Leading competitors show median viability as low as 84%, with high batch-to-batch variability that undermines treatment consistency.
Enzymes are costly consumables. Protocols require trained lab techs, incubators, and careful temperature management — a 5-person, multi-room operation that crushes your margins.
From lipoaspirate to injectable regenerative cells in under 3 minutes. Harvest, process, and inject in a single patient visit. No second appointment. No drop-off. Full revenue captured in one shot.
The WAVE uses proprietary shockwave technology — no enzymes, no chemical additives. Classified as minimal manipulation, giving you full regulatory confidence and protecting your license.
Gentle shockwave separation preserves cell integrity. Independent testing: 91.2% median viability vs. 84.2% for the leading competitor, with a standard deviation of just 2.6%.
A tabletop device. A closed sterile syringe. Press start. No enzymes to buy, no incubation to monitor, no specialized lab staff. One nurse and one physician — that's your entire team.
Why this matters for your clinic: The Synova WAVE's enzyme-free, closed-system processing keeps your adipose stem cell procedures firmly within the FDA's minimal manipulation framework. You're using the patient's own cells, processed mechanically in under 3 minutes, and re-injected in the same visit. That's the cleanest regulatory position in regenerative medicine — and it's the pathway the FDA has explicitly designed for point-of-care applications.
Here's the math that matters: the WAVE collapses a multi-visit, multi-staff, multi-hour procedure into a single same-day workflow. That compression is where all the money is.
When patients have to come back for a second visit, you lose them. Scheduling friction, life getting in the way, second thoughts — every multi-visit protocol leaks revenue. The WAVE makes it one appointment: harvest, process, inject, done. Your patient walks out treated. You captured the full $5K–$10K+ in a single session. No follow-up call. No re-booking. No drop-off.
Your longevity clientele — the ones already spending $2K on IV drips and $15K on comprehensive panels — don't want to come back next week. They want results now. "We harvest your own stem cells and inject them today, in the same visit" is a message that sells itself. It feels cutting-edge. It feels premium. And because it's the patient's own cells with zero chemical manipulation, you can market it honestly as the safest option available.
Stem cell therapy doesn't replace your existing menu — it sits at the top. A patient comes in for a joint consultation. You offer PRP at $1,200. Exosomes at $2,500. And now, autologous adipose stem cell injection at $7K–$10K+. Bundle it into a Platinum Regenerative Package with your existing IV therapies and diagnostic panels and you're looking at $12K–$15K per patient visit. The WAVE gives you a new top tier without adding operational complexity.
Enzymatic processing requires a trained lab tech ($60K–$80K/year), an incubator, enzyme inventory with cold-chain storage, and careful temperature management. The WAVE eliminates all of that. One tabletop device. Sterile single-use disposables. Your existing nurse loads the syringe, presses start, and hands the physician a ready-to-inject cell concentrate 3 minutes later. That's a 5-person, multi-room workflow compressed down to 2 people, 1 room.
When you're running one clinic, you can personally oversee quality. When you're running five or ten, you need a process that produces the same result every time, regardless of who operates it. The WAVE's 2.6% standard deviation means your Houston clinic and your Scottsdale clinic deliver identical cell quality. That's how you build a brand around outcomes — not just marketing.
FDA 510(k) clearance + enzyme-free processing + autologous cells = the cleanest regulatory position in regenerative medicine. While competitors operate in gray areas and risk enforcement actions, you're fully compliant. That's not just risk management — it's a competitive advantage. Patients trust FDA-cleared. Insurance partnerships require it. Investors demand it.
$5K–$10K+ per procedure, captured in one appointment. No second visit scheduling. No patient drop-off. Same-day harvest, process, inject — full revenue in one shot.
The SVF market is projected to exceed $5 billion by 2034, growing 12%+ annually. Clinics adopting point-of-care processing now will lead this wave — not chase it.
No enzymes. No lab techs. No incubators. One tabletop device with single-use disposables. Your operational overhead for stem cell procedures drops by 60–80%.
FDA 510(k) clearance + autologous cells + enzyme-free processing = the cleanest compliance position in regenerative medicine. Protect your license, your reputation, and your business.
Doctors want cutting-edge tools. Offering the WAVE signals your clinic is serious about regenerative medicine — making it easier to recruit and retain top clinical talent.
"3-minute, enzyme-free, FDA-cleared, same-day stem cell treatment using your own cells." In a crowded market, that's a differentiation message your competitors can't match.
91.2% median viability with 2.6% standard deviation means healthier, more potent regenerative cells — giving your patients the best possible chance at recovery.
Harvest, process, inject — all within a single visit. No second appointments. No waiting for lab results. Your patients leave the same day, treatment complete.
Patient's own cells, minimally manipulated, in a closed sterile system. Zero disease transmission risk. Zero immune rejection risk. The gold standard in patient safety.
Orthopedic joint repair, sports injuries, chronic wound healing, cosmetic fat grafting — adipose-derived stem cells have demonstrated regenerative potential across specialties.
Shockwave processing eliminates enzymatic variability. Lower standard deviation means predictable cell counts and reliable treatment protocols across every patient.
The SAVE (Shock-Assisted Viable Extraction) method is validated in published research, giving you confidence in the science behind every procedure you perform.
Standard mini-liposuction to collect adipose tissue. 15–20 minutes, local anesthesia.
Transfer lipoaspirate into the sterile, single-use syringe. Insert into the WAVE.
Press start. Shockwave impulses separate regenerative cells in ~3 minutes.
Concentrated cell pellet is ready. Inject directly into the treatment site. Same visit.
| Feature | Synova WAVE | Enzymatic (Collagenase) | Other Mechanical |
|---|---|---|---|
| Processing Time | ~3 minutes | 1–4 hours | 15–45 minutes |
| Median Cell Viability | 91.2% | 75–85% | 70–80% |
| Enzymes Required | None | Yes (collagenase) | None |
| FDA Compliance | 510(k) Cleared | Regulatory gray area | Varies |
| Avg. Viable Cells / cc | 122,000+ | Varies widely | Lower yields |
| Sterile Closed System | Yes | No (open processing) | Varies |
| Staff Required | Nurse + Physician | Lab tech + Physician + Support | 2–3 staff |
| Same-Day Treatment | Yes — single visit | Often requires 2nd visit | Possible but slower |
| Patient Experience | Premium, fast, modern | Long wait, clinical feel | Moderate |
The clinics adopting point-of-care adipose stem cell processing today are positioning themselves at the forefront of a multi-billion-dollar market shift. Early movers capture outsized value.
Position Your Clinic Now →Request a demo, get pricing, or talk to our clinical team about how the Synova WAVE fits into your practice and your P&L. No pressure — just the facts you need to make the right call.
Or call us directly: 1 (833) SYNOVA-1